China Medical GatewayLoading your healthcare gateway…

Endoscopic Submucosal Dissection (ESD) in China

Overview

Endoscopic submucosal dissection (ESD) removes early gastrointestinal cancers and large precancerous lesions in one piece, through the endoscope, curing the disease while preserving the organ. It was perfected in East Asia, where Chinese and Japanese centers hold the deepest experience.

For early gastric, esophageal and colonic neoplasia meeting curative criteria, ESD achieves oncologic outcomes equivalent to surgery with markedly faster recovery and preserved quality of life.

Symptoms & Signs

Indication is an endoscopic finding, not a symptom: early cancer or high-grade dysplasia on biopsy

Large lateral-spreading tumors of the colon

Early esophageal squamous neoplasia found on screening

Recurrent or non-lifting polyps after previous incomplete removal

Gastric lesions meeting absolute or expanded ESD criteria

Selected early cancers in patients unfit for or refusing surgery

Diagnosis

Magnifying endoscopy with NBI mapping lesion borders precisely

Endoscopic ultrasound confirming the lesion is confined to superficial layers

CT or PET-CT excluding lymph-node involvement

Biopsy confirming histology and grade

Curability assessment against established ESD criteria

Treatment Options

Marking, injection and circumferential incision of the lesion border

Submucosal dissection removing the lesion en bloc

Specimen pinning and histopathology verifying complete horizontal and vertical margins

Endoscopic closure of the defect where appropriate

Second-look endoscopy and scheduled surveillance

Rescue surgery when histology shows deeper invasion than expected

Advanced Technologies & Novel Drug

High-definition magnifying endoscopes with NBI

Specialized ESD knives and injection solutions

Endoscopic full-thickness resection for deeper lesions

AI lesion-boundary demarcation under evaluation at leading centers

Novel hemostatic and closure devices improving safety

Hospital & Specialist

Return to Home